Master post-approval CMC changes and pharmaceutical lifecycle management under ICH Q12. Learn how Established Conditions (ECs), PACMPs, and PLCM documents reduce regulatory burden, streamline EMA/FDA submissions, and drive continuous operational improvement across global supply chains.

]]>https://forum.thirdeyegen.com/topic/10539/ich-q12-post-approval-changes-in-2026-lifecycle-guide-zenovelRSS for NodeThu, 22 Oct 2026 23:30:28 GMTFri, 16 Oct 2026 17:42:29 GMT60